Concept information
Preferred term
Tripelennamine
Type
-
mesh:Descriptor
Definition
- A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Broader concept
Entry terms
- 1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-
- 154-69-8 (mono-HCl)
- 22306-05-4 (HCl)
- 30OC46A3J9
- 3C5ORO99TY
- 57116-36-6 (maleate)
- 58044-99-8 (maleate (1:1))
- 6138-56-3 (citrate (1:1))
- 91-81-6 (Tripelennamine)
- FWV8GJ56ZN
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-
-
154-69-8 (mono-HCl)
-
22306-05-4 (HCl)
-
30OC46A3J9
-
3C5ORO99TY
-
57116-36-6 (maleate)
-
58044-99-8 (maleate (1:1))
-
6138-56-3 (citrate (1:1))
-
91-81-6 (Tripelennamine)
-
FWV8GJ56ZN
URI
http://data.loterre.fr/ark:/67375/JVR-R7RKLC7D-T
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}